Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized starting dose of 6-mercaptopurine based on pharmacogenetics in pediatric acute lymphoblastic leukemia
KCT0006822Phase 2
Key facts
- Status
- Recruiting
- Start
- Jul 2019
- Countries
- 1
- Sponsor
- Ministry of Food and Drug Safety
- Modality
- Small Molecules
- Drugs
- mercaptopurine
- Conditions
- acute lymphoblastic leukemia (ALL)
01
Overview
Phase 2 trial of mercaptopurine in acute lymphoblastic leukemia (ALL), sponsored by Ministry of Food and Drug Safety. Started Jul 2019; status: recruiting.
02
Who it enrols
Pediatric patients with acute lymphoblastic leukemia in Korea, not healthy volunteers.
Beyond the preview
Go deeper on KCT0006822.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0006822.